Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Prometheus Materials develops bio-cement with zero carbon emissions to reduce the global CO2 emissions.
Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock.
AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.
HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.
Nitrase Therapeutics is developing drugs against newly discovered nitration enzyme(s).
Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.
Synthace is a SaaS Life Sciences R&D Digital Experiment Platform.
T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.
Real Leather, Reinvented
myTomorrows is a global platform that connects patients with unmet medical needs to treatments in development around the world.
iOmx Therapeutics focuses on the development of cancer immunotherapy treatments.
Sphere Bio specializes in tools for single cell analysis and isolation, facilitating discovery in the biotech field.
l'école AI is a computer vision-focused development platform.
Mablink Bioscience is a biotechnology company.
A French biotechnology company that uses precision fermentation to produce real dairy products, accessible to everyone.
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.
BrightHeart is a medical technology startup that is developing artificial intelligence software.
Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.
DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
Excelsior Sciences applies AI and automated chemistry to simplify small-molecule discovery and accelerate overall drug development.
AFYREN develop innovation in biotechnologies for the valorization of non-food biomass and in respect of the environment.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
Elevara is a clinical-stage firm working on innovative therapies to treat rheumatoid arthritis and other chronic inflammatory disorders.
Sofinnova Partners has invested in 148 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sofinnova Partners's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Medical, Therapeutics. The firm invests across 20 different industry categories.
Among tracked funding rounds, Hemab received $157.0M in a Series C round. Sofinnova Partners's total known invested capital is $6.3B.
Sofinnova Partners's average investment size is $48.1M across its portfolio of 148 companies.
Recent Sofinnova Partners portfolio additions include Prometheus Materials, Inotrem, AAVantgarde Bio, HotSpot Therapeutics, Nitrase Therapeutics. These companies were founded in 2020 or later.